Learn about endometrial cancer

Endometrial cancer is a malignant tumor originating from the endometrial glands, also known as uterine body cancer, most of which are adenocarcinomas. It is one of the three major malignant tumors of the female genitalia. In my country, endometrial cancer is much lower than cervical cancer, but in some developed Western countries, this disease is higher than cervical cancer and ranks first among gynecological malignancies.

The peak age for endometrial cancer is 58-61 years old, accounting for about 7% of all female cancers and 25% of reproductive tract malignancies. The incidence rate has been on the rise in recent years, approaching or even exceeding that of cervical cancer. It is related to long-term estrogen stimulation, obesity, hypertension, diabetes, infertility or sterility, menopause and other physical and genetic factors.

The treatment principle of endometrial cancer is to choose the appropriate treatment method according to the patient's age, physical condition, lesion range and histological type. Since the vast majority of endometrial cancers are adenocarcinomas, which are not very sensitive to radiotherapy, surgery is the main treatment. Other comprehensive treatments include radiotherapy, chemotherapy and drugs (chemotherapy, hormones, etc.). Early patients are mainly treated with surgery, and adjuvant therapy is selected according to the results of surgical-pathological staging and high-risk factors for recurrence; advanced patients are treated with comprehensive treatment including surgery, radiotherapy and drugs.